{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:38:39Z","timestamp":1780411119939,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Japan Medical Association, Center for Clinical Trials"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12185-015-1887-9","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T01:22:21Z","timestamp":1444785741000},"page":"654-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy"],"prefix":"10.1007","volume":"102","author":[{"given":"Yoshitaka","family":"Miyakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Katsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shosaku","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichi","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Shirasugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Kanakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingo","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"key":"1887_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12185-011-0791-1","volume":"93","author":"Y Kurata","year":"2011","unstructured":"Kurata Y, Fujimura K, Kuwana M, Tomiyama Y, Murata M. Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review. Int J Hematol. 2011;93:329\u201335.","journal-title":"Int J Hematol"},{"key":"1887_CR2","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","volume":"97","author":"JE Portielje","year":"2001","unstructured":"Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549\u201354.","journal-title":"Blood"},{"key":"1887_CR3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1532\/IJH97.04146","volume":"81","author":"K Fujimura","year":"2005","unstructured":"Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Ikeda Y, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicate chronic ITP cases in Japan. Int J Hematol. 2005;81:162\u20138.","journal-title":"Int J Hematol"},{"key":"1887_CR4","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","volume":"104","author":"K Kojouri","year":"2004","unstructured":"Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004;104:2623\u201334.","journal-title":"Blood"},{"key":"1887_CR5","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190\u2013207.","journal-title":"Blood"},{"key":"1887_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-013-1370-4","volume":"98","author":"H Kashiwagi","year":"2013","unstructured":"Kashiwagi H, Tomiyama Y. Pathophysiology and management of primary immune thrombocytopenia. Int J Hematol. 2013;98:24\u201333.","journal-title":"Int J Hematol"},{"issue":"Suppl 73","key":"1887_CR7","first-page":"25","volume":"32","author":"RJ Looney","year":"2005","unstructured":"Looney RJ. B-cell targeted therapy in diseases other than rheumatoid arthritis. J Rheumatol. 2005;32(Suppl 73):25\u20138.","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"1887_CR8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar3910","volume":"15","author":"V Reddy","year":"2013","unstructured":"Reddy V, Jayne D, Close D, Isenberg D. B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design. Arthritis Res Ther. 2013;15(Suppl 1):S2.","journal-title":"Arthritis Res Ther"},{"key":"1887_CR9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","volume":"120","author":"British Committee for Standards in Haematology General Haematology","year":"2003","unstructured":"British Committee for Standards in Haematology General Haematology. Task force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574\u201396.","journal-title":"Br J Haematol"},{"key":"1887_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168\u201386.","journal-title":"Blood"},{"key":"1887_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","volume":"146","author":"DM Arnold","year":"2007","unstructured":"Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25\u201333.","journal-title":"Ann Intern Med"},{"key":"1887_CR12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2008-01-131029","volume":"112","author":"B Godeau","year":"2008","unstructured":"Godeau B, Porcher R, Fain O, Lefr\u00e8re F, Fenaux P, Cheze S, et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood. 2008;112:999\u20131004.","journal-title":"Blood"},{"key":"1887_CR13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","volume":"371","author":"DJ Kuter","year":"2008","unstructured":"Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008;371:395\u2013403.","journal-title":"Lancet"},{"key":"1887_CR14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2141.2004.04889.x","volume":"125","author":"N Cooper","year":"2004","unstructured":"Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, et al. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol. 2004;125:232\u20139.","journal-title":"Br J Haematol"},{"key":"1887_CR15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.exphem.2006.02.009","volume":"34","author":"F Zaja","year":"2006","unstructured":"Zaja F, Vianelli N, Battista M, Sperotto A, Patriarca F, Tomadini V, et al. Earlier administration of rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia. Exp Hematol. 2006;34:571\u20132.","journal-title":"Exp Hematol"},{"key":"1887_CR16","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/j.seminhematol.2013.03.005","volume":"50","author":"D Siegal","year":"2013","unstructured":"Siegal D, Crowther M, Cuker A. Thrombopoietin receptor agonists in primary ITP. Semin Hematol. 2013;50:S18\u201321.","journal-title":"Semin Hematol"},{"key":"1887_CR17","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood-2014-06-582346","volume":"124","author":"M Khellaf","year":"2014","unstructured":"Khellaf M, Charles-Nelson A, Fain O, Terriou L, Viallard JF, Cheze S, et al. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients. Blood. 2014;124:3228\u201336.","journal-title":"Blood"},{"key":"1887_CR18","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2009-07-229815","volume":"115","author":"F Zaja","year":"2010","unstructured":"Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A, et al. Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood. 2010;115:2755\u201362.","journal-title":"Blood"},{"key":"1887_CR19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12185-010-0753-z","volume":"93","author":"Z Li","year":"2011","unstructured":"Li Z, Mou W, Lu G, Cao J, He X, Pan X, et al. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia. Int J Hematol. 2011;93:91\u20138.","journal-title":"Int J Hematol"},{"key":"1887_CR20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/blood-2011-08-374777","volume":"119","author":"DM Arnold","year":"2012","unstructured":"Arnold DM, Heddle NM, Carruthers J, Cook DJ, Crowther MA, Meyer RM, et al. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood. 2012;119:1356\u201362.","journal-title":"Blood"},{"key":"1887_CR21","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2012-09-455691","volume":"121","author":"S Gudbrandsdottir","year":"2013","unstructured":"Gudbrandsdottir S, Birgens HS, Frederiksen H, Jensen BA, Jensen MK, Kjeldsen L, et al. Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia. Blood. 2013;121:1976\u201381.","journal-title":"Blood"},{"key":"1887_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjh.13029","volume":"167","author":"H Tran","year":"2014","unstructured":"Tran H, Brighton T, Grigg A, McRae S, Dixon J, Thurley D, et al. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study). Br J Haematol. 2014;167:243\u201351.","journal-title":"Br J Haematol"},{"key":"1887_CR23","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(14)61495-1","volume":"385","author":"W Ghanima","year":"2015","unstructured":"Ghanima W, Khelif A, Waage A, Michel M, Tj\u00f8nnfjord GE, Romdhan NB, et al. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2015;385:1653\u201361.","journal-title":"Lancet"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1887-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-015-1887-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-015-1887-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:11:27Z","timestamp":1559437887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-015-1887-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1887"],"URL":"https:\/\/doi.org\/10.1007\/s12185-015-1887-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}